NewLink Genetics (NLNK) Tops Q3 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts NLNK Hot Sheet
Join SI Premium – FREE
NewLink Genetics (NASDAQ: NLNK) reported Q3 EPS of ($0.55), $0.11 better than the analyst estimate of ($0.66).
Cash position:
NewLink Genetics ended the quarter on September 30, 2015, with cash, cash equivalents, and certificates of deposit totaling $200.4 million, compared to $202.8 million for the year ending December 31, 2014.
Guidance:
NewLink Genetics expects to have more than $160 million in cash and equivalents on December 31, 2015.
For earnings history and earnings-related data on NewLink Genetics (NLNK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Xperi Corporation (XPER) Tops Q3 EPS by 3c; Offers Guidance
- Paycom Software (PAYC) Tops Q3 EPS by 56c, Beats on Revenue; Offers FY26 Revenue Guidance
- a.k.a. Brands Holding Corp. (AKA) Misses Q3 EPS by 37c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
